glp-1 lake mary fl Lisa Otero, NP-C | Hormone & Longevity Medicine Menopause & Hormone Therapy |

GLP-1 agonists have body weight and blood pressure benefits in addition to lowering blood glucose concentrations

Thus, this modest increase in LDL-C may be misleading regarding ASCVD risk, as patients with obesity may have a higher concentration of atherogenic small, dense LDL particles, and therefore high levels of apoB for a given blood LDL-C [10, 13]

This was because they were unconvinced an appropriate regulatory route could be found for proceeding with the substance for obesity

Subscribe to receive weekly insights from Trilliant Health's Research Team

Tirzepatide in type 1 diabetes: single-centre observational cohort (N=26), 2025